Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

[Detection and Diagnostic Values of JAK2, CALR, MPL Gene Mutations in 208 Cases of BCR/ABL1 Negative Chronic Myeloproliferative Diseases].

Li ZL, Gao L, Zhang H, Zhang CX, Chen YR, Huang FZ, Gong M, Gao YY, Tang Y, Ma YG.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Aug;26(4):1122-1128. doi: 10.7534/j.issn.1009-2137.2018.04.030. Chinese.

PMID:
30111418
2.

CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms.

Ojeda MJ, Bragós IM, Calvo KL, Williams GM, Carbonell MM, Pratti AF.

Hematology. 2018 May;23(4):208-211. doi: 10.1080/10245332.2017.1385891. Epub 2017 Oct 9.

PMID:
28990497
3.

Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India.

Rabade N, Subramanian PG, Kodgule R, Raval G, Joshi S, Chaudhary S, Mascarenhas R, Tembhare P, Gujral S, Patkar N.

Indian J Pathol Microbiol. 2018 Apr-Jun;61(2):209-213. doi: 10.4103/IJPM.IJPM_223_17.

4.

The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms.

Lin Y, Liu E, Sun Q, Ma J, Li Q, Cao Z, Wang J, Jia Y, Zhang H, Song Z, Ai X, Shi L, Feng X, Li C, Wang J, Ru K.

Am J Clin Pathol. 2015 Jul;144(1):165-71. doi: 10.1309/AJCPALP51XDIXDDV.

PMID:
26071474
5.

[Analysis of CALR, JAK2 and MPL gene mutations in BCR-ABL negative myeloproliferative neoplasms].

Ouyang Y, Qiao C, Wang J, Xiao L, Zhang S.

Zhonghua Yi Xue Za Zhi. 2015 May 12;95(18):1369-73. Chinese.

PMID:
26178351
6.

[Clinical significance of JAK2、CALR and MPL gene mutations in 1 648 Philadelphia chromosome negative myeloproliferative neoplasms patients from a single center].

Li MY, Chao HY, Sun AN, Qiu HY, Jin ZM, Tang XW, Han Y, Fu CC, Chen SN, Wu DP.

Zhonghua Xue Ye Xue Za Zhi. 2017 Apr 14;38(4):295-300. doi: 10.3760/cma.j.issn.0253-2727.2017.04.007. Chinese.

PMID:
28468090
7.

Coexisting JAK2V617F and CALR Exon 9 Mutations in Myeloproliferative Neoplasms - Do They Designate a New Subtype?

Ahmed RZ, Rashid M, Ahmed N, Nadeem M, Shamsi TS.

Asian Pac J Cancer Prev. 2016;17(3):923-6. Review.

9.

Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.

Michiels JJ, Berneman Z, Schroyens W, De Raeve H.

Acta Haematol. 2015;133(1):36-51. doi: 10.1159/000358580. Epub 2014 Aug 7. Review.

PMID:
25116092
10.

Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients.

Limsuwanachot N, Rerkamnuaychoke B, Chuncharunee S, Pauwilai T, Singdong R, Rujirachaivej P, Chareonsirisuthigul T, Siriboonpiputtana T.

Hematology. 2017 Dec;22(10):599-606. doi: 10.1080/10245332.2017.1312736. Epub 2017 Apr 13.

PMID:
28406068
11.

The mutation profile of JAK2, MPL and CALR in Mexican patients with Philadelphia chromosome-negative myeloproliferative neoplasms.

Labastida-Mercado N, Galindo-Becerra S, Garcés-Eisele J, Colunga-Pedraza P, Guzman-Olvera V, Reyes-Nuñez V, Ruiz-Delgado GJ, Ruiz-Argüelles GJ.

Hematol Oncol Stem Cell Ther. 2015 Mar;8(1):16-21. doi: 10.1016/j.hemonc.2014.12.002. Epub 2015 Jan 21.

12.

Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia.

Rashid M, Ahmed RZ, Ahmed S, Nadeem M, Ahmed N, Shamsi TS.

Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):112-116. doi: 10.1007/s12288-016-0658-y. Epub 2016 Feb 9.

13.

Somatic mutations of calreticulin in myeloproliferative neoplasms.

Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, Them NC, Berg T, Gisslinger B, Pietra D, Chen D, Vladimer GI, Bagienski K, Milanesi C, Casetti IC, Sant'Antonio E, Ferretti V, Elena C, Schischlik F, Cleary C, Six M, Schalling M, Schönegger A, Bock C, Malcovati L, Pascutto C, Superti-Furga G, Cazzola M, Kralovics R.

N Engl J Med. 2013 Dec 19;369(25):2379-90. doi: 10.1056/NEJMoa1311347. Epub 2013 Dec 10.

14.

Calreticulin exon 9 mutations in myeloproliferative neoplasms.

Ha JS, Kim YK.

Ann Lab Med. 2015 Jan;35(1):22-7. doi: 10.3343/alm.2015.35.1.22. Epub 2014 Dec 8.

15.

Correlation analysis between JAK2, MPL, and CALR mutations in patients with myeloproliferative neoplasms of Chinese Uygur and Han nationality and their clinical characteristics.

Lang T, Nie Y, Wang Z, Huang Q, An L, Wang Y, Wufuer G, Maimaiti A, Fu L, Li Y, Zhang X, Aisimutula A, Wang X, Zhu L, Liu H, Mao M.

J Int Med Res. 2018 Nov;46(11):4650-4659. doi: 10.1177/0300060518787719. Epub 2018 Aug 7.

16.

Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.

Misawa K, Yasuda H, Araki M, Ochiai T, Morishita S, Shirane S, Edahiro Y, Gotoh A, Ohsaka A, Komatsu N.

Int J Hematol. 2018 Jun;107(6):673-680. doi: 10.1007/s12185-018-2421-7. Epub 2018 Feb 20.

PMID:
29464483
17.

The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms.

Wu Z, Zhang X, Xu X, Chen Y, Hu T, Kang Z, Li S, Wang H, Liu W, Ma X, Guan M.

J Hematol Oncol. 2014 Jul 15;7:48. doi: 10.1186/s13045-014-0048-6.

18.

Development of a Targeted Next-Generation Sequencing Assay to Detect Diagnostically Relevant Mutations of JAK2, CALR, and MPL in Myeloproliferative Neoplasms.

Frawley T, O'Brien CP, Conneally E, Vandenberghe E, Percy M, Langabeer SE, Haslam K.

Genet Test Mol Biomarkers. 2018 Feb;22(2):98-103. doi: 10.1089/gtmb.2017.0203. Epub 2018 Jan 11.

PMID:
29323541
19.

JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia.

Wang J, Zhang B, Chen B, Zhou RF, Zhang QG, Li J, Yang YG, Zhou M, Shao XY, Xu Y, Xu XH, Ouyang J, Xu J, Ye Q.

Hematology. 2017 Apr;22(3):145-148. doi: 10.1080/10245332.2016.1252003. Epub 2016 Nov 22.

PMID:
27875935
20.

[Mutation of CALR Gene in Patients with Chronic Myeloproliferative Neoplasm and Its Clinical Significance].

Tang Q, Zhang XW, Xia L, Jiang NK.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Feb;25(1):151-156. doi: 10.7534/j.issn.1009-2137.2017.01.027. Chinese.

PMID:
28245393

Supplemental Content

Support Center